Axim Biotechnologies Reports Third Quarter 2017 Results

NEW YORK, Nov. 22, 2017 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced results for the quarter ended September 30, 2017, and provided an overview of recent operational highlights. Read More

The post Axim Biotechnologies Reports Third Quarter 2017 Results appeared first on Dagga Magazine.

…read more

Leave a Reply

Your email address will not be published. Required fields are marked *